These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38091558)

  • 1. Preexposure Prophylaxis Uptake Among Spanish-Speaking Transgender Women: A Randomized Controlled Trial in North and South Carolina, 2019-2022.
    Rhodes SD; Alonzo J; Mann-Jackson L; Aviles LR; Tanner AE; Galindo CA; Bessler PA; Courtenay-Quirk C; Garcia M; Sucaldito AD; Smart BD; Goldenberg T; Reboussin BA
    Am J Public Health; 2024 Jan; 114(1):68-78. PubMed ID: 38091558
    [No Abstract]   [Full Text] [Related]  

  • 2. Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic.
    Rhodes SD; Tanner AE; Mann-Jackson L; Alonzo J; Refugio Aviles L; Galindo CA; Bessler PA; Courtenay-Quirk C; Smart BD; Garcia M; Goldenberg T; Sucaldito AD; Reboussin BA
    AIDS Educ Prev; 2022 Dec; 34(6):481-495. PubMed ID: 36454131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Locally Developed Interventions to Promote PrEP Among Racially/Ethnically Diverse Transgender Women in the United States: A Unique CDC Initiative.
    Rhodes SD; Kuhns LM; Alexander J; Alonzo J; Bessler PA; Courtenay-Quirk C; Denson DJ; Evans K; Galindo CA; Garofalo R; Gelaude DJ; Hotton AL; Johnson AK; Mann-Jackson L; Muldoon A; Ortiz R; Paul JL; Perloff J; Pleasant K; Reboussin BA; Refugio Aviles L; Song EY; Tanner AE; Trent S
    AIDS Educ Prev; 2021 Aug; 33(4):345-360. PubMed ID: 34370565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
    Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM
    Lancet Infect Dis; 2014 Jun; 14(6):468-75. PubMed ID: 24613084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial.
    Agustí C; Martínez Riveros H; García-Pérez J; Descalzo V; Fernandez G; Ramírez-Marinero A; Gonzalez MV; Díaz Y; Montoro-Fernandez M; Romano-deGea P; Araujo SG; Muntada E; Casabona J
    BMJ Open; 2023 Oct; 13(10):e073459. PubMed ID: 37844988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low awareness but high acceptability of pre-exposure prophylaxis for HIV among men who have sex with men and transgender persons in Delhi, India.
    Sethi AK; Haldar P; Rai SK; Kant S; Rajan S; Kumar P; Mishra JK; Singh B
    Int J STD AIDS; 2023 Oct; 34(11):763-776. PubMed ID: 37269245
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Entre Nosotras:" a qualitative study of a peer-led PrEP project for transgender latinas.
    Zamudio-Haas S; Koester K; Venegas L; Salinas A; Herrera C; Gutierrez-Mock L; Welborn L; Deutsch MB; Sevelius J
    BMC Health Serv Res; 2023 Sep; 23(1):1013. PubMed ID: 37730598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and Discontinuation of Pre-Exposure Prophylaxis Among Uninsured Transgender and Cisgender Women: A Public-Private Partnership Model in North Carolina.
    Zarwell M; Witt B; Marin-Cespedes S; Gorman B; Kumtap MU; Hoff R; Rysbayeva A; Jha P; Boehm EL; Harihar S; Issel LM; Robinson P
    AIDS Patient Care STDS; 2023 Nov; 37(11):525-534. PubMed ID: 37956243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
    Swendeman D; Rotheram-Borus MJ; Arnold EM; Fernández MI; Comulada WS; Lee SJ; Ocasio MA; Ishimoto K; Gertsch W; Duan N; Reback CJ; Murphy DA; Lewis KA;
    Lancet Digit Health; 2024 Mar; 6(3):e187-e200. PubMed ID: 38395539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Testing and Preexposure Prophylaxis Prescriptions Among U.S. Commercially Insured Transgender Men and Women, 2014 to 2021.
    Huang YA; Radix A; Zhu W; Kimball AA; Olansky EJ; Hoover KW
    Ann Intern Med; 2024 Jan; 177(1):12-17. PubMed ID: 38109739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Gender Affirmation and HIV and Sexually Transmitted Disease Prevention in Transgender Youth: Results from the Survey of Today's Adolescent Relationships and Transitions, 2018.
    Andrzejewski J; Dunville R; Johns MM; Michaels S; Reisner SL
    LGBT Health; 2021 Apr; 8(3):181-189. PubMed ID: 33566718
    [No Abstract]   [Full Text] [Related]  

  • 17. Embedding a Linkage to Preexposure Prophylaxis Care Intervention in Social Network Strategy and Partner Notification Services: Results From a Pilot Randomized Controlled Trial.
    Teixeira da Silva D; Bouris A; Ramachandran A; Blocker O; Davis B; Harris J; Pyra M; Rusie LK; Brewer R; Pagkas-Bather J; Hotton A; Ridgway JP; McNulty M; Bhatia R; Schneider JA
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):191-199. PubMed ID: 33109935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.